Tech Company Financing Transactions

Presage Biosciences Funding Round

Presage Biosciences, based in Seattle, raised investment capital from Takeda Ventures.

Transaction Overview

Announced On
9/30/2015
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
530 Fairview Ave. North 1000
Seattle, WA 98109
USA
Email Address
Overview
Presage Biosciences was founded in November, 2008 based on technology invented in the laboratory of Dr. James Olson, a pediatric oncologist focused on brain tumors.
Profile
Presage Biosciences LinkedIn Company Profile
Social Media
Presage Biosciences Company Twitter Account
Company News
Presage Biosciences News
Facebook
Presage Biosciences on Facebook
YouTube
Presage Biosciences on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Richard Klinghoffer
  Richard Klinghoffer LinkedIn Profile  Richard Klinghoffer Twitter Account  Richard Klinghoffer News  Richard Klinghoffer on Facebook
Vice President
Kirsten Anderson
  Kirsten Anderson LinkedIn Profile  Kirsten Anderson Twitter Account  Kirsten Anderson News  Kirsten Anderson on Facebook
VP - Operations
Jon Williams
  Jon Williams LinkedIn Profile  Jon Williams Twitter Account  Jon Williams News  Jon Williams on Facebook
VP - R & D
John Streeter
  John Streeter LinkedIn Profile  John Streeter Twitter Account  John Streeter News  John Streeter on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/30/2015: Blue Prairie Brands venture capital transaction
Next: 9/30/2015: Grafly venture capital transaction

 

Share this article

 


Where The Data Comes From

We document all VC transactions involving tech companies. VC investment data records reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary